PCN Strengthens Supply Chain Capacity and Childhood Pneumonia Response Through New Partnerships

The Pharmacy Council of Nigeria (PCN) has signed Memoranda of Collaboration (MoCs) with the Africa Resource Centre for Excellence in Supply Chain Management (ARC-ESM) and Nemel Pharmaceuticals Limited, establishing new partnerships focused on regulatory capacity, supply chain development and childhood pneumonia management.

The agreements were signed as part of efforts to strengthen the Council’s institutional capacity and support public health interventions involving pharmacy professionals and Patent and Proprietary Medicine Vendors (PPMVs).

Supply Chain Upskilling Partnership

Under the MoC with ARC-ESM, the two organisations will establish an institutional framework for a Supply Chain Upskilling Partnership.

The partnership is designed to build foundational supply chain knowledge among designated PCN staff while supporting access to internationally recognised professional certifications.

Beyond staff development, the collaboration is intended to contribute to strengthening PCN’s supply chain regulatory system. Improved supply chain capacity within a regulatory institution can support more effective oversight of pharmaceutical and healthcare commodity systems.

Focus on Childhood Pneumonia

The second MoC, signed with Nemel Pharmaceuticals Limited, establishes a formal framework for collaboration on a project aimed at increasing knowledge among Community Pharmacists and Patent and Proprietary Medicine Vendors (PPMVs) on the identification and appropriate management of childhood pneumonia.

The initiative places community-level medicine providers within a broader public health response to childhood pneumonia, particularly by improving their knowledge of recognising suspected cases and responding appropriately within the limits of their professional and regulatory responsibilities.

Under the partnership, PCN will provide governance and regulatory guidance, while Nemel Pharmaceuticals will serve as the project sponsor and implementation partner.

Why the Partnerships Matter

The two agreements address different but complementary areas of health-system strengthening.

For PCN, developing internal supply chain expertise could enhance the Council’s capacity to regulate and engage with pharmaceutical supply systems. Meanwhile, strengthening the knowledge of community pharmacists and PPMVs on childhood pneumonia could support earlier recognition of illness and more appropriate referral and management at community level.

The partnerships also demonstrate the importance of collaboration between regulatory institutions, supply chain organisations and the private sector in addressing health-system and public health priorities.

For pharmacy practice, the childhood pneumonia initiative is particularly relevant because community-based medicine providers are often among the first points of contact for families seeking care for children.

The effectiveness of the initiative will ultimately depend on the quality of training, the clarity of referral pathways, adherence to national treatment guidelines and appropriate regulatory oversight.

The agreements therefore represent more than institutional partnerships: they provide a framework for building professional capacity while linking pharmacy regulation and community-level public health action.